Udagawa O, Kato-Udagawa A, Hirano S
Biol Open. 2022; 11(6).
PMID: 35579421
PMC: 9194678.
DOI: 10.1242/bio.059130.
Patra U, Muller S
Front Cell Dev Biol. 2021; 9:696234.
PMID: 34513832
PMC: 8430037.
DOI: 10.3389/fcell.2021.696234.
Hofmann S, Mai J, Masser S, Groitl P, Herrmann A, Sternsdorf T
Adv Sci (Weinh). 2020; 7(8):1902130.
PMID: 32328411
PMC: 7175289.
DOI: 10.1002/advs.201902130.
Xu P, Roizman B
Proc Natl Acad Sci U S A. 2017; 114(19):E3823-E3829.
PMID: 28439026
PMC: 5441741.
DOI: 10.1073/pnas.1703395114.
Miciak J, Bunz F
Biochim Biophys Acta. 2016; 1865(2):220-7.
PMID: 26951863
PMC: 4860023.
DOI: 10.1016/j.bbcan.2016.03.001.
Sp100 isoform-specific regulation of human adenovirus 5 gene expression.
Berscheminski J, Wimmer P, Brun J, Ip W, Groitl P, Horlacher T
J Virol. 2014; 88(11):6076-92.
PMID: 24623443
PMC: 4093896.
DOI: 10.1128/JVI.00469-14.
Emerging Cellular Functions of Cytoplasmic PML.
Jin G, Wang Y, Lin H
Front Oncol. 2013; 3:147.
PMID: 23761861
PMC: 3674320.
DOI: 10.3389/fonc.2013.00147.
The adenoviral oncogene E1A-13S interacts with a specific isoform of the tumor suppressor PML to enhance viral transcription.
Berscheminski J, Groitl P, Dobner T, Wimmer P, Schreiner S
J Virol. 2012; 87(2):965-77.
PMID: 23135708
PMC: 3554061.
DOI: 10.1128/JVI.02023-12.
A structural basis for the assembly and functions of a viral polymer that inactivates multiple tumor suppressors.
Ou H, Kwiatkowski W, Deerinck T, Noske A, Blain K, Land H
Cell. 2012; 151(2):304-19.
PMID: 23063122
PMC: 3681303.
DOI: 10.1016/j.cell.2012.08.035.
The cell biology of TRIM5α.
Lukic Z, Campbell E
Curr HIV/AIDS Rep. 2011; 9(1):73-80.
PMID: 22193888
PMC: 3501103.
DOI: 10.1007/s11904-011-0102-8.
Human pathogens and the host cell SUMOylation system.
Wimmer P, Schreiner S, Dobner T
J Virol. 2011; 86(2):642-54.
PMID: 22072786
PMC: 3255802.
DOI: 10.1128/JVI.06227-11.
Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells.
Schreiner S, Wimmer P, Sirma H, Everett R, Blanchette P, Groitl P
J Virol. 2010; 84(14):7029-38.
PMID: 20484509
PMC: 2898266.
DOI: 10.1128/JVI.00074-10.
PML nuclear bodies.
Lallemand-Breitenbach V, de The H
Cold Spring Harb Perspect Biol. 2010; 2(5):a000661.
PMID: 20452955
PMC: 2857171.
DOI: 10.1101/cshperspect.a000661.
A role for cytoplasmic PML in cellular resistance to viral infection.
McNally B, Trgovcich J, Maul G, Liu Y, Zheng P
PLoS One. 2008; 3(5):e2277.
PMID: 18509536
PMC: 2386554.
DOI: 10.1371/journal.pone.0002277.
A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.
Netherton C, Moffat K, Brooks E, Wileman T
Adv Virus Res. 2007; 70:101-82.
PMID: 17765705
PMC: 7112299.
DOI: 10.1016/S0065-3527(07)70004-0.
Induction of promyelocytic leukemia (PML) oncogenic domains (PODs) by papillomavirus.
Nakahara T, Lambert P
Virology. 2007; 366(2):316-29.
PMID: 17543368
PMC: 2777652.
DOI: 10.1016/j.virol.2007.04.032.
Spatial and temporal organization of adeno-associated virus DNA replication in live cells.
Fraefel C, Bittermann A, Bueler H, Heid I, Bachi T, Ackermann M
J Virol. 2003; 78(1):389-98.
PMID: 14671120
PMC: 303420.
DOI: 10.1128/jvi.78.1.389-398.2004.
Adenovirus protein IX sequesters host-cell promyelocytic leukaemia protein and contributes to efficient viral proliferation.
Rosa-Calatrava M, Puvion-Dutilleul F, Lutz P, Dreyer D, de The H, Chatton B
EMBO Rep. 2003; 4(10):969-75.
PMID: 14528266
PMC: 1326401.
DOI: 10.1038/sj.embor.embor943.
Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization.
Rosa-Calatrava M, Grave L, Chatton B, Kedinger C
J Virol. 2001; 75(15):7131-41.
PMID: 11435594
PMC: 114442.
DOI: 10.1128/JVI.75.15.7131-7141.2001.
Regulation of matrix attachment region-dependent, lymphocyte-restricted transcription through differential localization within promyelocytic leukemia nuclear bodies.
Zong R, Das C, Tucker P
EMBO J. 2000; 19(15):4123-33.
PMID: 10921892
PMC: 306587.
DOI: 10.1093/emboj/19.15.4123.